We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.05 | 0.20 | 0.125 | 0.125 | 0.13 | 4,085,813 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.59M | -1.69M | -0.0037 | -0.32 | 544.67k |
Date | Subject | Author | Discuss |
---|---|---|---|
10/7/2017 12:51 | And down we go again. No doubt this pile of poo will be sold off for the benefit of management and directors with the long suffering small shareholder picking up the bill. Same old same old | brownson | |
28/6/2017 17:13 | Don't be so unwise as to think people only buy based on actual risk. A significant proportion of the spending decisions we make in our lives are based on all manner of illogical perceptions and beliefs. | milesy | |
28/6/2017 06:26 | Maybe, but a slick sales force, alarmist headlines and fickle public can be used as leverage on these huge public chains and more-the market worldwide is enormous-to spend properly on infection control and cleanliness which, as we are all aware, is atrocious (do all these scruffy, transient and temporary waiters and baristas really comply as they should}. Byotrol has a tiny market cap-a smart ceo should be able to capitalize on what is an important and sensitive public health issue to grow it. imo | cumnor | |
27/6/2017 16:53 | Unfortunately Byotrol seem to have the answer to which there is no problem | brownson | |
27/6/2017 16:25 | Most are brownson thats true but apparently Byotrols is the exception with its 24hr protection being given EPA approval in the States. Pretty hot for a UK minnow imo. APPROVAL RECEIVED FROM U.S. ENVIRONMENTAL PROTECTION AGENCY ("EPA") FOR LONG-LASTING ANTI-MICROBIAL PRODUCT Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that the US EPA has formally approved Byotrol's proprietary 24-hour germ-kill surface sanitizer for sale in the US (EPA Reg. Number 83614-1). The formulation has been under development at Byotrol for over seven years and the Directors believe offers unique performance characteristics to US consumers and businesses. To US consumers our products will be able to claim high performance cleaning and viricidal action, plus long-lasting benefits such as: -- 24-hour surface protection against bacteria -- Scientifically proven to kill >99.9% of bacteria for 24 hours -- 7 day mold and mildew prevention -- Eliminates >99.9% of viruses The Directors are not aware of any other cleaning or sanitizing products that can make such claims for US consumers; we believe this approval gives Byotrol a unique opportunity in the substantial US market. | bad gateway | |
18/6/2017 14:57 | Wisecat, agree good to see shares rotating into new hands. Not an easy co to value due to the EPA approval, nvt someone with US distribution could pay a lot for this Whilst this is under the radar as regards investors I suspect that is not the case with the industry. | slicethepie | |
16/6/2017 16:45 | Slicethepie determined seller yes but determined buyer as well over 10m shares traded this week late trades on Tuesday show 8.3m traded. Rocket ready.... | wisecat2 | |
14/6/2017 09:31 | I see that finnCap raised their price target by 30% to 9p following yesterday's news | timbo003 | |
13/6/2017 19:26 | Seems to me like a pretty determined seller out there, very happy to have been able to buy more at these levels | slicethepie | |
13/6/2017 17:18 | no reason to sell these - tree shaking following the big rise by market makers here - i bet. my guess is they are short of stock. | emeraldzebra | |
13/6/2017 11:39 | Always been short of money for that sort of frippery ;¬) I thought the takeover back in March was a good deal too - always been about margin for me, and that was a very sensible move in the right direction. Excitement muted for that too, but should have a good long-term benefit. Taken together, the rocket should be well-justified given a little time. | supernumerary | |
13/6/2017 11:26 | Quite a muted reaction It would almost certainly help if they actually employed a PR agency or arranged for an interview or two on VOX markets, Proactive, BRR media etc, if only to give shareholders and investors some sort of context. I will bring up their non-existent PR at the next AGM (although I mentioned it at the last one to no avail) | timbo003 | |
13/6/2017 07:41 | A unique, consumer meaningful claim (which presumably comes with a veritable fortress of IP protection) in the US is going to be worth many, many times the current market cap (circa £12m) to Consumer product behemoths such as Reckitts, Unilever etc | timbo003 | |
13/6/2017 07:32 | £70k? | maxk | |
13/6/2017 07:30 | ……… | timbo003 | |
13/6/2017 07:13 | Wow!! Never thought they'd get that with US regs on cleaners so tough. Now they've got sole accesss to a $1b market. Might be a budding IDP here. | bad gateway | |
13/6/2017 07:09 | Well done! This is a massive achievement for a uk company | slicethepie | |
24/3/2017 13:12 | Blimey Mud...bet that cured the insomnia! I note it was for a PhD thesis, but didn't see if it was paid for/sponsored research? | milesy | |
23/3/2017 10:14 | Some essential reading for Byotrollers. | mudbath | |
13/3/2017 20:17 | I am told by a friend who knew of the new Chairman John Langlands that he is some one who knows what he is doing. I bought in at 4.1p, so lets see. Anybody got any comments about the capital value of Byotrol at £10m. | paulbristol | |
13/3/2017 20:16 | I am told by a friend who knew of the new Chairman John Langlands that he is some one who knows what he is doing. I bought in at 4.1p, so lets see. Anybody got any comments about the capital value of Byotrol at £10m. | paulbristol | |
13/3/2017 10:51 | Bizarre really. Nathan Winch, CEO at WinchPharma commented, “I’d always been in touch with David; we had a good relationship from the start. They [Byotrol plc.] were instrumental in providing the technology required to make this project a reality… “ | mudbath | |
13/3/2017 08:23 | Well it's not retirement Nathan Winch only 27! Maybe BYOT were looking to end distribution deal to bring sales in house and came to a mutually beneficial settlement for the NHS licence? They control the supply so hold the cards. | cockerhoop | |
13/3/2017 07:54 | Sorry bb2. | maxk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions